v3.26.1
BACKGROUND AND ORGANIZATION (Details Narrative)
Aug. 30, 2022
₨ / shares
shares
Mar. 31, 2026
$ / shares
shares
Jan. 23, 2026
$ / shares
shares
Dec. 31, 2025
$ / shares
shares
Oct. 25, 2024
Mar. 17, 2022
$ / shares
shares
Sep. 21, 2018
$ / shares
shares
Oct. 05, 2017
$ / shares
shares
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                
Common stock, shares authorized   400,000,000   400,000,000        
Common stock par value | $ / shares   $ 0.001 $ 0.06 $ 0.001        
Common stock, shares authorized   50,000,000   50,000,000        
Preferred stock, par value | $ / shares   $ 0.001   $ 0.001        
Common stock, shares outstanding   113,361,886   108,147,731        
Common stock, shares issued   113,361,886 4,716,000 108,147,731        
Pharmalectin India Pvt Ltd [Member]                
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                
Common stock, shares authorized 50,000              
Common stock par value | ₨ / shares ₨ 10              
Common stock, shares outstanding 41,020              
Outstanding shares held 41,000              
Outstanding shares percentage 99.95%              
Pharmalectin (BVI), Inc. [Member]                
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                
Common stock, shares authorized           50,000    
Common stock par value | $ / shares           $ 1.00    
Outstanding shares held           50,000    
NDPD Pharma Inc [Member]                
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                
Common stock, shares authorized               95,000,000
Common stock par value | $ / shares               $ 0.000
Common stock, shares authorized               5,000,000
Preferred stock, par value | $ / shares               $ 0.0001
Common stock, shares outstanding   15,000,000            
Common stock acquired percentage         100.00%      
Common stock, shares issued   15,000,000            
Parent Company [Member]                
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                
Common stock, shares authorized             400,000,000 95,000,000
Common stock par value | $ / shares             $ 0.001 $ 0.0001
Common stock, shares authorized             50,000,000 5,000,000
Preferred stock, par value | $ / shares             $ 0.001 $ 0.0001
Pharmalectin, Inc. [Member]                
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                
Common stock, shares authorized               95,000,000
Common stock par value | $ / shares               $ 0.0001
Common stock, shares authorized               5,000,000
Preferred stock, par value | $ / shares               $ 0.0001
Common stock, shares outstanding   15,000,000